Burkholderia cepacia: This decision is overdue

PDA Journal of Pharmaceutical Science and Technology

Volumn 65, Issue 5, 2011, Pages 535-543

  Torbeck, Lynn ^a   Raccasi, Diane ^b   Guilfoyle, Dennis E ^b   Friedman, Richard L ^b   Hussong, David ^b  

^a Torbeck and Assoc   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; BIOFILM; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DRUG CONTAMINATION; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; MICROBIAL CONTAMINATION; NONHUMAN; PRODUCT RECALL; REVIEW; BURKHOLDERIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTION; IMMUNOLOGY; MICROBIOLOGY;

BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DRUG CONTAMINATION; HUMANS; SOIL MICROBIOLOGY;

EID: 83755173183     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: 10.5731/pdajpst.2011.00793     Document Type: Review

References (30)

1. Torbeck, L. Recall Root Cause Analysis. FDA/ PDA Joint Regulatory Conference, Washington, DC, September 9, 2008.
2. Torbeck, L.; Friedman, R.; Smedley, M. An overview of CDER's Recall Root Cause Assessment Project. Pharm. Technol. 2009, 33 (8), 42-45.
3. Friedman, R.; Smedley, M.; Torbeck, L.; Santiago, I. An initial report of CDER's Recall Root Cause Assessment Project. Pharm. Technol. 2011, 35 (1), 66-69.
4. Holmes, A.; Govan, J.; Goldstein, R. Agricultural use of Burkholderia (Pseudomonas) cepacia A threat to human health? Emerg. Infect. Dis. 1998, 4 (2), 221-227. (Pubitemid 28311208)
5. Vandamme, P. Burkholderia cepacia: Pandora's Box redefined. BCCM News 2001, 9, 2-3.
6. Sousa, S. A.; Ramos, C. G.; Leitão, J. H. Burkholderia cepacia complex: Emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int. J. Microbiol. 2011, doi:10.1155/2011/607575.
7. Mandell, L.; Bennett, E.; Dolin, R. Principles and practice of infectious diseases. Churchill Livingstone, 2000.
8. Miller, S. C. M.; LiPuma, J. J.; Parke, J. Culture-based and non-growth-dependent detection of the Burkholderia cepacia complex in soil environments. Appl. Environ. Microbiol. 2002, 68 (8), 3750-3758.
9. Jimenez, L. Microbial Contamination Control in the Pharmaceutical Industry; Marcel Dekker: New York, 2004.
10. Vial, L.; Chapalain, A.; Groleau, M. C.; Deziel, E. Minireview - the various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation. Environmental Microbiology 2011, 13 (1), 1-12.
11. Gilligan, P.; Whittier, S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, and Adidoboras; Murray, P, Baron, E., Pfaller, M., Tenover, F., Yolken, R. Manual of Clinical Microbiology, American Society for Microbiology, Washington, D.C., 1999, p 526.
12. Carson, L.; Favero, M. S.; Bond, W. W.; Peterson, N. J. Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl. Microbiol. 1973, 25 (3), 476-483.
13. Donlan, R. M. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7 (2), 277-281. (Pubitemid 32374344)
14. Anwar, H.; Dasgupta, M. K.; Costerton, J. W. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother. 1990, 34 (11), 2043-2046. (Pubitemid 20373829)
15. Department of Health and Human Services, Office of Compliance, Bureau of Drugs. "Letter to the pharmaceutical industry, RE: Validation and control of deionized water systems." August 1981.
16. FDA Guide to Inspections of Microbiological Pharmaceutical Quality Control Laboratories. 1993.
17. Luigi, C. Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol. 2006, 14 (6), 277-286.
18. World Health Organization. Antimicrobial resistance, Fact sheet, No. 194. (Online). Updated January 2002. http://www.who.int/mediacentre/ factsheets/fs194/en/index.html.
19. Moore, J.; Elborn, J. Burkholderia cepacia and cystic fibrosis. http://www.cysticfirbrosismedicine. com, 2003.
20. De Soyza, A.; McDowell, A.; Archer, L.; Dark, J. H.; Elborn, S. J.; Mahenthiralingam, E.; Gould, K.; Corris, P. A. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001, 358 (9295), 1780-1781. (Pubitemid 33153006)
21. Chaparro, C.; Maurer, J.; Gutierrez, C.; Krajden, M.; Chan, C.; Winton, T.; Keshavjee, S.; Scavuzzo, M.; Tullis, E.; Hutcheon, M.; Kesten, S. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am. J. Respir. Crit. Care Med. 2001, 163 (1), 43-48. (Pubitemid 32095251)
22. Ledson, M. Outcome of Burkholderia cepacia colonization in an adult cystic fibrosis centre. Thorax 2002, 57 (2) 142-145. (Pubitemid 34123888)
23. Kaper, J.; Saylor, G.; Baldini, M.; Colwell, R. Ambient-temperature primary nonselective enrichment for isolation for Salmonella spp. from an estuarine environment. Appl. Environ. Microbiol. 1977, 33 (4) 829-835. (Pubitemid 8086619)
24. Henry, D.; Campbell, M.; McGimpsey, C.; Clarke, A.; Louden, L.; Burns, J. L.; Roe, M. H.; Vandamme, P.; Speert, D. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 1999, 37 (4) 1004-1007. (Pubitemid 29140605)
25. United States Pharmacopeia. USP 〈61〉 Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests. United States Pharmacopeial Convention: Rockville, MD, 2008.
26. United States Pharmacopeia. USP 〈62〉 Microbiological Examination of Non-Sterile Products: Tests for Specified Microorganisms. United States Pharmacopeial Convention: Rockville, MD, 2008.
27. United States Pharmacopeia. USP 〈63〉 Mycoplasma. United States Pharmacopeial Convention: Rockville, MD, 2008.
28. United States Pharmacopeia. USP 〈1111〉 Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use. United States Pharmacopeial Convention: Rockville, MD, 2008.
29. Halls, N. Burkholderia (Pseudomonas) cepacia - a brief profile for the pharmaceutical microbiologist. Eur. J. Parent. Pharm. Sci. 2006, 11 (2) 53.
30. FDA Investigations Operations Manual. 7.1 Recalls, 2008.